# Biomat USA, Inc. – FDA Inspection, Jan 9, 2025

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/1d0c4be5-f678-41ad-a309-6a86b7948f85
Source feed: FDA_Inspections

> FDA inspection 1258091 of Biomat USA, Inc., January 09, 2025. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 606. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1258091
- Company Name: Biomat USA, Inc.
- Inspection Date: 2025-01-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Denver District Office
- Citation Count: 4

## Related Documents

- FDA Inspection 1053346 - 2018-04-06

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/emily-b-camire/dff5f4c6-bcbe-4ef1-ac0b-1b2701b311ef)

Company: https://www.keypedia.com/companies/biomat-usa-inc/c28f6e5c-6b5f-422f-a482-3c4159472560

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face
